Skip to main content

Urinary Stones

0
Pipeline Programs
1
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Avvio Medical
Avvio MedicalCA - San Francisco
3 programs
Acoustic Enhancer for Laser LithotripsyN/A
Enhanced Lithotripsy SystemN/A4 trials
Ureteroscopy Laser LithotripsyN/A1 trial
Active Trials
NCT06942949Recruiting101Est. Jul 2026
NCT04771182Terminated25Est. Oct 2022
NCT03339388Terminated13Est. Oct 2022
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Avvio MedicalEnhanced Lithotripsy System
Avvio MedicalUreteroscopy Laser Lithotripsy
Avvio MedicalEnhanced Lithotripsy System
Avvio MedicalEnhanced Lithotripsy System
Avvio MedicalEnhanced Lithotripsy System

Clinical Trials (5)

Total enrollment: 338 patients across 5 trials

NCT06942949Avvio MedicalEnhanced Lithotripsy System

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Start: May 2025Est. completion: Jul 2026101 patients
N/ARecruiting
NCT04563039Avvio MedicalUreteroscopy Laser Lithotripsy

Acoustic Enhancer Research on Laser Lithotripsy (AEROLITH)

Start: May 2021Est. completion: Jul 2023196 patients
N/ACompleted
NCT04771182Avvio MedicalEnhanced Lithotripsy System

Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

Start: Feb 2019Est. completion: Oct 202225 patients
N/ATerminated
NCT03339388Avvio MedicalEnhanced Lithotripsy System

Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

Start: Dec 2017Est. completion: Oct 202213 patients
N/ATerminated
NCT03195920Avvio MedicalEnhanced Lithotripsy System

Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease

Start: Jul 2017Est. completion: Oct 20223 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 338 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.